Ann: December 2016 Appendix 4C - Quarterly, page-9

Discursive,a fun post...but seriously I think the fun may be just beginning...someone has been quietly accumulating up to 9c ...no more at 9c left...so it broken through...low number of shares,9 million in the bank,well managed,brilliant research team,3 active trials,plenty of news in the pipeline!The AML 1b/2 trial began on the 18/12/16...initial dose at 25mg/m2 and it should be now on the 3rd cycle of 4 cycles if the dose cycle of 21 days is used...each cycle increases the dose by 10mg/m2...testing toxicity...so far so good...no news is good news and the longer the trial goes the more the speculation mounts as more patients are dosed...if the toxicity proves successful,it then comes down to the efficacy and that will not be disclosed until all the results are collated .
By the end of the year if all goes to plan this could have a MC of between $60-100 million..all imho.